Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia

Jiuxin Qu, Li Gu, Jiang Wu, Jianping Dong, Zenghui Pu, Yan Gao, Ming Hu, Yongxiang Zhang, Feng Gao, Bin Cao, Chen Wang, Beijing Network for Adult Community-Acquired Pneumonia (BNACAP), Jiuxin Qu, Li Gu, Jiang Wu, Jianping Dong, Zenghui Pu, Yan Gao, Ming Hu, Yongxiang Zhang, Feng Gao, Bin Cao, Chen Wang, Beijing Network for Adult Community-Acquired Pneumonia (BNACAP)

Abstract

Background: Diagnosis of community-acquired pneumonia (CAP) caused by Mycoplasma pneumoniae in adults and adolescents is hampered by a lack of rapid and standardized tests for detection.

Methods: CAP patients from 12 teaching hospitals were prospectively and consecutively recruited. Basic and clinical information, throat swabs and paired sera were collected. Mycoplasma pneumoniae was detected by IgG and IgM antibody tests, fluorescence quantitative polymerase chain reaction (FQ-PCR) and culture. A comparative study of the diagnostic values of three methods, including sensitivity, specificity, positive and negative predictive values and positive likelihood ratio (PLR) was conducted. A fourfold or greater increase of IgG antibody titers of paired sera was set as the diagnostic "gold standard".

Results: One hundred and twenty-five CAP patients (52.8% males, median age 47 years, range 14-85) were enrolled. Twenty-seven (21.6%) patients were diagnosed with acute Mycoplasma pneumoniae infections by the "gold standard". Specificity values of all three methods were around 90%. An increasing trend of sensitivity, positive predictive value and PLR was found, with the lowest in IgM testing (7.4%, 28.6% and 1.45), intermediate in FQ-PCR (40.7%, 50% and 3.63), and highest in culture (55.6%, 75% and 10.9).

Conclusions: In the defined group of patients, there was a good agreement between positive rate of MP cultivation of throat swabs and acute M. pneumoniae infection (PLR of 10.9). Since the sensitivity is low in all of the evaluated methods, the logical approach would be to incorporate PCR, culture and serological tests for optimum diagnosis of acute Mycoplasma pneumoniae infections in adults and adolescents.

References

    1. Loens K, Goossens H, Ieven M. Acute respiratory infection due to mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis. 2010;29(9):1055–1069. doi: 10.1007/s10096-010-0975-2.
    1. Liu Y, Chen M, Zhao T, Wang H, Wang R, Cai B, Cao B, Sun T, Hu Y, Xiu Q. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in chinese urban population. BMC Infect Dis. 2009;9:31. doi: 10.1186/1471-2334-9-31.
    1. Cao B, Ren LL, Zhao F, Gonzalez R, Song SF, Bai L, Yin YD, Zhang YY, Liu YM, Guo P. Viral and mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur J Clin Microbiol Infect Dis. 2010;29(11):1443–1448. doi: 10.1007/s10096-010-1003-2.
    1. Lieberman D, Schlaeffer F, Lieberman D, Horowitz S, Horovitz O, Porath A. Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration. 1996;63(5):261–266. doi: 10.1159/000196557.
    1. Principi N, Esposito S, Blasi F, Allegra L. Role of mycoplasma pneumoniae and chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis. 2001;32(9):1281–1289. doi: 10.1086/319981.
    1. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728. doi: 10.1128/CMR.17.4.697-728.2004. table of contents.
    1. She RC, Thurber A, Hymas WC, Stevenson J, Langer J, Litwin CM, Petti CA. Limited utility of culture for mycoplasma pneumoniae and chlamydophila pneumoniae for diagnosis of respiratory tract infections. J Clin Microbiol. 2010;48(9):3380–3382. doi: 10.1128/JCM.00321-10.
    1. Thacker WL, Talkington DF. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol. 2000;7(5):778–780.
    1. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–273. doi: 10.1046/j.1469-0691.2003.00590.x.
    1. Gnarpe J, Lundback A, Sundelof B, Gnarpe H. Prevalence of mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis. 1992;24(2):161–164. doi: 10.3109/00365549209052607.
    1. Foy HM. Infections caused by mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17(Suppl 1):S37–S46.
    1. Waites KB, Nolte FS. Laboratory diagnosis of mycoplasmal infections. Washington, D.C.: ASM Press; 2001.
    1. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ Clinical research ed. 2004;329(7458):168–169. doi: 10.1136/bmj.329.7458.168.
    1. Yin YD, Zhao F, Ren LL, Song SF, Liu YM, Zhang JZ, Cao B. Evaluation of the japanese respiratory society guidelines for the identification of mycoplasma pneumoniae pneumonia. Respirology. 2012;17(7):1131–1136. doi: 10.1111/j.1440-1843.2012.02227.x.
    1. von Baum H, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the german competence network for community-acquired pneumonia (CAPNETZ) BMC Infect Dis. 2009;9:62. doi: 10.1186/1471-2334-9-62.
    1. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–1495.
    1. Moule JH, Caul EO, Wreghitt TG. The specific IgM response to mycoplasma pneumoniae infection: interpretation and application to early diagnosis. Epidemiol Infect. 1987;99(3):685–692. doi: 10.1017/S0950268800066541.
    1. Jacobs E. Serological diagnosis of mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis. 1993;17(Suppl 1):S79–S82.
    1. Ieven M, Ursi D, Van Bever H, Quint W, Niesters HG, Goossens H. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. Pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis. 1996;173(6):1445–1452. doi: 10.1093/infdis/173.6.1445.
    1. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpaa R, Mertsola J, Ruuskanen O. Diagnosis of mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998;36(11):3155–3159.
    1. Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008;8:93. doi: 10.1186/1471-2180-8-93.
    1. Morozumi M, Hasegawa K, Chiba N, Iwata S, Kawamura N, Kuroki H, Tajima T, Ubukata K. Application of PCR for mycoplasma pneumoniae detection in children with community-acquired pneumonia. J Infect Chemother. 2004;10(5):274–279. doi: 10.1007/s10156-004-0338-y.
    1. Touati A, Benard A, Hassen AB, Bebear CM, Pereyre S. Evaluation of five commercial real-time PCR assays for detection of mycoplasma pneumoniae in respiratory tract specimens. J Clin Microbiol. 2009;47(7):2269–2271. doi: 10.1128/JCM.00326-09.
    1. Dumke R, Jacobs E. Comparison of commercial and in-house real-time PCR assays used for detection of mycoplasma pneumoniae. J Clin Microbiol. 2009;47(2):441–444. doi: 10.1128/JCM.01989-08.
    1. Raty R, Ronkko E, Kleemola M. Sample type is crucial to the diagnosis of mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol. 2005;54(Pt 3):287–291.
    1. Dorigo-Zetsma JW, Verkooyen RP, van Helden HP, van der Nat H, van den Bosch JM. Molecular detection of mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J Clin Microbiol. 2001;39(3):1184–1186. doi: 10.1128/JCM.39.3.1184-1186.2001.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner